<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Biol. Chem</journal-id>
<journal-id journal-id-type="hwp">jbc</journal-id>
<journal-id journal-id-type="pmc">jbc</journal-id>
<journal-id journal-id-type="publisher-id">JBC</journal-id>
<journal-title-group>
<journal-title>The Journal of Biological Chemistry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9258</issn>
<issn pub-type="epub">1083-351X</issn>
<publisher>
<publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name>
<publisher-loc>11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A.</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27856640</article-id>
<article-id pub-id-type="pmc">5207145</article-id>
<article-id pub-id-type="publisher-id">M116.763235</article-id>
<article-id pub-id-type="doi">10.1074/jbc.M116.763235</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Signal Transduction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>G protein-coupled receptors (GPCRs) That Signal via Protein Kinase A (PKA) Cross-talk at Insulin Receptor Substrate 1 (IRS1) to Activate the phosphatidylinositol 3-kinase (PI3K)/AKT Pathway<xref ref-type="fn" rid="FN1">*</xref><xref ref-type="fn" rid="FN2"><sup><inline-graphic xlink:href="sbox.jpg"></inline-graphic></sup></xref></article-title>
<alt-title alt-title-type="short">GPCRs and IGF1R Cross-talk at IRS1 to Activate PI3K</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Law</surname>
<given-names>Nathan C.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>White</surname>
<given-names>Morris F.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>§</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hunzicker-Dunn</surname>
<given-names>Mary E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1">From the <label>‡</label>School of Molecular Biosciences, Washington State University, Pullman, Washington 99164 and </aff>
<aff id="aff2">the <label>§</label>Division of Endocrinology, Dept. of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>1</label> To whom correspondence should be addressed: <addr-line>School of Molecular Biosciences, Washington State University, Biotechnology Life Sciences Bldg., Rm. 233, Pullman, WA 99164-7520.</addr-line> Tel.: <phone>509-335-5614</phone>; E-mail: <email>mehd@wsu.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Jeffrey E. Pessin</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>30</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>17</day>
<month>11</month>
<year>2016</year>
</pub-date>
<volume>291</volume>
<issue>53</issue>
<fpage>27160</fpage>
<lpage>27169</lpage>
<history>
<date date-type="received">
<day>13</day>
<month>10</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>14</day>
<month>11</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>The American Society for Biochemistry and Molecular Biology, Inc.</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="zbc05316027160.pdf"></self-uri>
<abstract>
<p>G protein-coupled receptors (GPCRs) activate PI3K/v-AKT thymoma viral oncoprotein (AKT) to regulate many cellular functions that promote cell survival, proliferation, and growth. However, the mechanism by which GPCRs activate PI3K/AKT remains poorly understood. We used ovarian preantral granulosa cells (GCs) to elucidate the mechanism by which the GPCR agonist FSH via PKA activates the PI3K/AKT cascade. Insulin-like growth factor 1 (IGF1) is secreted in an autocrine/paracrine manner by GCs and activates the IGF1 receptor (IGF1R) but, in the absence of FSH, fails to stimulate Y<italic>XX</italic>M phosphorylation of IRS1 (insulin receptor substrate 1) required for PI3K/AKT activation. We show that PKA directly phosphorylates the protein phosphatase 1 (PP1) regulatory subunit myosin phosphatase targeting subunit 1 (MYPT1) to activate PP1 associated with the IGF1R-IRS1 complex. Activated PP1 is sufficient to dephosphorylate at least four IRS1 Ser residues, Ser<sup>318</sup>, Ser<sup>346</sup>, Ser<sup>612</sup>, and Ser<sup>789</sup>, and promotes IRS1 Y<italic>XX</italic>M phosphorylation by the IGF1R to activate the PI3K/AKT cascade. Additional experiments indicate that this mechanism also occurs in breast cancer, thyroid, and preovulatory granulosa cells, suggesting that the PKA-dependent dephosphorylation of IRS1 Ser/Thr residues is a conserved mechanism by which GPCRs signal to activate the PI3K/AKT pathway downstream of the IGF1R.</p>
</abstract>
<kwd-group>
<kwd>G protein-coupled receptor (GPCR)</kwd>
<kwd>insulin receptor substrate 1 (IRS1)</kwd>
<kwd>insulin-like growth factor (IGF)</kwd>
<kwd>PI3K</kwd>
<kwd>PKA</kwd>
</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source>National Institute of Child Health and Human Development
<named-content content-type="funder-id">http://dx.doi.org/10.13039/100000071</named-content></funding-source>
<award-id>R01HD065859</award-id>
<award-id>R01HD062053</award-id>
</award-group>
<award-group id="award2">
<funding-source>National Institute of General Medical Sciences
<named-content content-type="funder-id">http://dx.doi.org/10.13039/100000057</named-content></funding-source>
<award-id>T32GM083864</award-id>
</award-group>
<award-group id="award3">
<funding-source>National Institute of Diabetes and Digestive and Kidney Diseases
<named-content content-type="funder-id">http://dx.doi.org/10.13039/100000062</named-content></funding-source>
<award-id>R01DK098655–01</award-id>
<award-id>R01DK038712–22</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>